Objective Evaluation of Patients with Rheumatic Diseases. II. Paper Electrophoretic Studies of Serum Glycoprotein and Protein from Patients with Rheumatoid Arthritis

Research Laboratory, VA Hospital, Oklahoma City, Okla.

Department of Biochemistry, University of Oklahoma School of Medicine, Oklahoma City, Okla.

Department of Pharmacology, University of Oklahoma School of Medicine, Oklahoma City, Okla.

These studies were supported in part by grants from Geigy Pharmaceuticals Division of Geigy Chemical Corporation, Ardsley, N. Y., and from the Oklahoma Chapter of the Arthritis and Rheumatism Foundation with funds made available by the United Fund of Oklahoma City.

Find articles by Stidworthy, G. in: JCI | PubMed | Google Scholar

Research Laboratory, VA Hospital, Oklahoma City, Okla.

Department of Biochemistry, University of Oklahoma School of Medicine, Oklahoma City, Okla.

Department of Pharmacology, University of Oklahoma School of Medicine, Oklahoma City, Okla.

These studies were supported in part by grants from Geigy Pharmaceuticals Division of Geigy Chemical Corporation, Ardsley, N. Y., and from the Oklahoma Chapter of the Arthritis and Rheumatism Foundation with funds made available by the United Fund of Oklahoma City.

Find articles by Payne, R. in: JCI | PubMed | Google Scholar

Research Laboratory, VA Hospital, Oklahoma City, Okla.

Department of Biochemistry, University of Oklahoma School of Medicine, Oklahoma City, Okla.

Department of Pharmacology, University of Oklahoma School of Medicine, Oklahoma City, Okla.

These studies were supported in part by grants from Geigy Pharmaceuticals Division of Geigy Chemical Corporation, Ardsley, N. Y., and from the Oklahoma Chapter of the Arthritis and Rheumatism Foundation with funds made available by the United Fund of Oklahoma City.

Find articles by Shetlar, C. in: JCI | PubMed | Google Scholar

Research Laboratory, VA Hospital, Oklahoma City, Okla.

Department of Biochemistry, University of Oklahoma School of Medicine, Oklahoma City, Okla.

Department of Pharmacology, University of Oklahoma School of Medicine, Oklahoma City, Okla.

These studies were supported in part by grants from Geigy Pharmaceuticals Division of Geigy Chemical Corporation, Ardsley, N. Y., and from the Oklahoma Chapter of the Arthritis and Rheumatism Foundation with funds made available by the United Fund of Oklahoma City.

Find articles by Shetlar, M. in: JCI | PubMed | Google Scholar